Position in NVS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$477,525
+$12,096 QoQ
Shares Held
3,047
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#905
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KLINGENSTEIN FIELDS & CO LP holds $198,349,712 across 10 Drug Manufacturers - General names. NVS ranks #7 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
91,363 | $109,583,531 | |
| 2 | JNJ |
Johnson & Johnson
|
218,394 | $55,465,523 | |
| 3 | MRK |
Merck & Co., Inc.
|
223,496 | $28,719,236 | |
| 4 | ABBV |
AbbVie Inc.
|
5,534 | $1,392,575 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
8,138 | $1,028,154 | |
| 6 | BIIB |
Biogen Inc.
|
2,731 | $590,059 | |
| 7 | NVS |
Novartis AG
This page
|
3,047 | $477,525 | |
| 8 | NVO |
Novo Nordisk A S
|
9,380 | $449,677 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $477,525 | 3,047 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $465,429 | 3,047 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $420,089 | 3,047 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $390,747 | 3,047 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $792,252 | 6,547 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $729,859 | 6,547 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $661,416 | 6,797 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $781,790 | 6,797 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $723,608 | 6,797 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $681,269 | 7,043 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $882,780 | 8,743 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $839,631 | 8,243 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $831,801 | 8,243 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $758,356 | 8,243 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $837,164 | 9,228 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $702,484 | 9,242 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $781,226 | 9,242 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $724,551 | 8,257 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $829,128 | 9,479 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $798,990 | 9,770 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $801,269 | 8,782 | Shares | Other | 2021-07-26 | |
| 2021-03-31 | $760,942 | 8,902 | Shares | Other | 2021-04-29 | |
| 2020-12-31 | $840,615 | 8,902 | Shares | Other | 2021-02-02 | |
| 2020-09-30 | $756,725 | 8,702 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $760,032 | 8,702 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $717,479 | 8,702 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||